Institut Catala dOncologia (ICO Hospitalet)

Barcelona 08908

3 studies enrolling now · 4 studies all time

What they study most

Metastatic Head-and-neck Squamous-cell Carcinoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Multiple Myeloma, Recurrent Head and Neck Squamous Cell Carcinoma, Relapsed/Refractory Aggressive B-Cell Lymphoma, Smoldering Multiple Myeloma (SMM)

Studies at this site

• A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma — Recruiting now
• A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment — Recruiting now
• A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma — Recruiting now
• A Study to Learn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients With B-cell Malignancies — Completed